The Influence of KDR Genetic Variation on the Efficacy and Safety of Patients With Advanced NSCLC Receiving First-Line Bevacizumab Plus Chemotherapy Regimen.
Technology In Cancer Research & Treatment
Geng, Nan N; Su, Jingwei J; Liu, Zhikun Z; Ding, Cuimin C; Xie, Shaonan S; Hu, Wenxia W